enow.com Web Search

  1. Ads

    related to: new treatment for migraine headaches medications approved by doctors
    • Sign Up Today

      Learn About a Treatment Option.

      Sign Up to Receive More Info.

    • Take the Quiz

      Become Familiar With the Treatment.

      Take the Quiz Today.

Search results

  1. Results from the WOW.Com Content Network
  2. This New Nasal Spray Could Provide Migraine Relief in ... - AOL

    www.aol.com/nasal-spray-could-migraine-relief...

    Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?

  3. FDA approves Pfizer's new nasal spray treatment for migraines

    www.aol.com/news/fda-approves-pfizers-nasal...

    The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.

  4. 17 expert-approved ways to relieve migraine pain ... - AOL

    www.aol.com/news/17-expert-approved-ways-relieve...

    Generally, these tricks are used "as an adjunct to medication treatments to help get rid of a migraine when you have one," Dr. Susan Broner, neurologist and director of the headache program at ...

  5. Galcanezumab - Wikipedia

    en.wikipedia.org/wiki/Galcanezumab

    In September 2018, galcanezumab was approved in the United States for the preventive treatment of migraine in adults. [9] [10] The FDA granted the approval of Emgality to Eli Lilly. [9] [10] In November 2018, galcanezumab was approved for use in the European Union for the prophylaxis of migraine in adults who have at least four migraine days ...

  6. Ubrogepant - Wikipedia

    en.wikipedia.org/wiki/Ubrogepant

    Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. [4] [5] It is not indicated for the preventive treatment of migraine. [6] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.

  7. Ditan - Wikipedia

    en.wikipedia.org/wiki/Ditan

    The first ditan, Eli Lilly's lasmiditan, was approved by the FDA in 2019. Ditans selectively bind to the 5-HT 1F receptor subtype. A number of triptans have been shown to act on this subtype as well, but only after their affinity for 5-HT 1B and 5-HT 1D has been made responsible for their anti-migraine activity.

  1. Ads

    related to: new treatment for migraine headaches medications approved by doctors